| 時間枠 | 予想価格 | 過去 | 歴史的 | 洞察力 |
|---|---|---|---|---|
| 明日 | $17.26 ▲ +1.15% | 昨日 | $16.98 ▼ -0.48% | Tomorrow's Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) setup is anchored to $17.06 and targets $17.26 (+1.15%). The near-term read is upside; watch $17.57 / $16.55 because daily realized volatility is about 5.93%. |
Tomorrow's Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) setup is anchored to $17.06 and targets $17.26 (+1.15%). The near-term read is upside; watch $17.57 / $16.55 because daily realized volatility is about 5.93%. | ||||
| 週 | $17.67 ▲ +3.58% | 先週 | $16.80 ▼ -1.50% | The 7-day Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) model moves from $16.80 to $17.67 (+3.58%). It gives upside momentum context for this stock, so breaks around $17.57 / $16.55 matter more than a single tick. |
The 7-day Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) model moves from $16.80 to $17.67 (+3.58%). It gives upside momentum context for this stock, so breaks around $17.57 / $16.55 matter more than a single tick. | ||||
| 月 | $18.36 ▲ +7.61% | 先月 | $16.51 ▼ -3.20% | The 1-month Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) target is $18.36 (+7.61%), compared with the live reference near $17.06. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) target is $18.36 (+7.61%), compared with the live reference near $17.06. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| 年 | $19.39 ▲ +13.67% | 去年 | $16.08 ▼ -5.74% | The 1-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) scenario points to $19.39 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) scenario points to $19.39 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5年 | $21.81 ▲ +27.86% | 5年前 | $15.06 ▼ -11.70% | The 5-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) view is $21.81 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) view is $21.81 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| インジケータ | 価値 | 信号 |
|---|---|---|
| Price | $17.06 | Mid |
| Daily Change | -2.79% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $17.06 | Daily Change | -2.79% |
| Market Cap | $53.69B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.